BrainStorm Cell Therapeutics
BCLI
#10709
Rank
ยฃ8.08 M
Marketcap
ยฃ0.73
Share price
6.52%
Change (1 day)
48.53%
Change (1 year)

Earnings for BrainStorm Cell Therapeutics (BCLI)

Earnings in 2026 (TTM): -ยฃ7.1 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -ยฃ7.71 Million, an increase over its 2024 earnings that were of -ยฃ8.7 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BrainStorm Cell Therapeutics from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -ยฃ7.1 Million-7.96%
2025 -ยฃ7.71 Million-11.32%
2024 -ยฃ8.7 Million-32.39%
2023 -ยฃ12.86 Million-29.18%
2022 -ยฃ18.16 Million-0.74%
2021 -ยฃ18.29 Million-23.12%
2020 -ยฃ23.79 Million36.8%
2019 -ยฃ17.39 Million66.71%
2018 -ยฃ10.44 Million181.66%
2017 -ยฃ3.71 Million-0.6%
2016 -ยฃ3.73 Million-41.31%
2015 -ยฃ6.35 Million-8.22%
2014 -ยฃ6.92 Million89.74%
2013 -ยฃ3.65 Million42.27%
2012 -ยฃ2.57 Million-12.45%
2011 -ยฃ2.93 Million63.04%
2010 -ยฃ1.8 Million35.52%
2009 -ยฃ1.33 Million-48.99%
2008 -ยฃ2.6 Million-44.39%
2007 -ยฃ4.67 Million
2005 -ยฃ2.42 Million-91.44%
2004 -ยฃ28.26 Million94007.62%
2003 -ยฃ0.04 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Biogen
BIIB
ยฃ1.21 B-17,059.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
ยฃ8.02 B-112,200.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Seagen
SGEN
-ยฃ0.6 Billion 8,160.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Cytokinetics
CYTK
-ยฃ0.63 Billion 8,568.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
ยฃ89.46 M-1,350.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Acceleron Pharma
XLRN
-ยฃ0.2 Billion 2,569.69%๐Ÿ‡บ๐Ÿ‡ธ USA